Stock CARM CARISMA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Carisma Therapeutics, Inc.

Equities

CARM

US14216R1014

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
1.33 USD +1.53% Intraday chart for Carisma Therapeutics, Inc. -1.48% -54.61%
May. 16 Carisma Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of CT-0525, A Novel HER2-Targeting CAR-Monocyte CI
May. 09 Carisma Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
CARISMA THERAPEUTICS, INC.
Bio Therapeutic Drugs
+1.53%-1.48%-54.61%-76.54% - 55.25M
Bearish
Bearish
Bearish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. CARM Stock
  4. Charts Carisma Therapeutics, Inc.
  5. Comparison Chart